21 October 2020 - - US-based biopharmaceutical manufacturing solutions and services provider ABEC is delivering process systems to Ology Bioservices Inc to support their production of critical vaccines and therapeutics for COVID-19, the company said.

ABEC is providing these systems to Ology Bioservices' Medical Countermeasures Advanced Development and Manufacturing (MCM ADM) facility in Alachua, Florida.

Ology Bioservices' MCM ADM is a flexible multi-product facility, utilizing stainless steel and single-use technologies to accelerate the production of vaccines and therapeutic antibodies.

As a full-service biologics contract development and manufacturing organization, Ology Bio selected ABEC for their ability to deliver customized bioprocess systems for solutions preparation and filtration applications on a fast-track schedule.

Complete in-house capabilities and significant global capacity for system and CSR single-use disposable container manufacturing enable ABEC to rapidly respond to the needs of biopharmaceutical industry leaders, such as Ology.

Since 1974, ABEC has been a leader in delivering integrated process solutions and services for manufacturing in the biopharmaceutical industry.

The majority of the world's pharmaceutical and biotech companies are ABEC customers; with many therapies manufactured by processes and equipment engineered, manufactured, installed, and serviced by ABEC.

Ology Bio is a privately held, full-service Contract Development Manufacturing Organization serving both government and commercial clients, specializing in biologic drug substance manufacturing from early stage through commercial product.

The company has 183,000 square feet of manufacturing, process development and QA/QC space in its state-of-the-art Advanced Development and Manufacturing Facility in Florida.

The company's infrastructure provides unique services to its clients, including full regulatory support from preclinical through licensure, clinical trial operational support and bioanalytical testing, as well as CGMP manufacturing up to Biosafety Level 3.

Ology Bio has more than 20 years' experience developing and manufacturing drugs and biologics for the US government, with over USD 1.8bn in government contracts awarded.

The team at Ology Bio has decades of experience manufacturing, developing and licensing vaccines and protein/antibody therapeutics.